Praziquantel/Pyrantel Pamoate/Febantel

Verify with FDA CVM →

268 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
268
Total Reports
14
Deaths Reported
520.0%
Death Rate

Active Ingredients

Praziquantel/Pyrantel Pamoate/Febantel

Administration Routes

OralUnknownTopicalOther

Species Affected

Dog 262
Unknown 3
Cat 2
Human 1

Most Affected Breeds

Dog (unknown) 58
Chihuahua 24
Crossbred Canine/dog 17
Retriever - Labrador 15
Mixed (Dog) 12
Shih Tzu 10
Shepherd Dog - German 9
Retriever - Golden 9
Terrier - Yorkshire 7
Boxer (German Boxer) 7

Most Reported Reactions

Vomiting 71
Diarrhoea 47
Emesis (multiple) 40
Emesis 32
Anorexia 27
Lethargy (see also Central nervous system depression in 'Neurological') 26
Loose stool 16
Lack of efficacy (endoparasite) - tapeworm 15
Underdose 13
Death 11
Behavioural disorder NOS 10
INEFFECTIVE, WORMS 9

Outcome Breakdown

Outcome Unknown
146 (55.3%)
Recovered/Normal
100 (37.9%)
Died
11 (4.2%)
Ongoing
4 (1.5%)
Euthanized
3 (1.1%)

Data Summary

Metric Value
Total adverse event reports 268
Reports involving death 14
Case-fatality rate (reported events) 520.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Praziquantel/Pyrantel Pamoate/Febantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 268 adverse event reports referencing Praziquantel/Pyrantel Pamoate/Febantel, including 14 reports in which the animal died — a 520.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Praziquantel/Pyrantel Pamoate/Febantel. Reported administration routes include Oral, Unknown, Topical, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Praziquantel/Pyrantel Pamoate/Febantel reports are Dog (262 reports), Unknown (3 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Dog (unknown) (58), Chihuahua (24), Crossbred Canine/dog (17) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Praziquantel/Pyrantel Pamoate/Febantel are Vomiting (71), Diarrhoea (47), Emesis (multiple) (40), Emesis (32). Of the 264 reports with a coded outcome, Outcome Unknown is the leading category at 55.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Praziquantel/Pyrantel Pamoate/Febantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial